Followers | 179 |
Posts | 24889 |
Boards Moderated | 16 |
Alias Born | 04/03/2002 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 22, 2022 2:48:10 PM
----------------------------------------------------------------------------------------------------------
Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT and proBEAT. sugarBEAT, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the U.S. as a general wellness product as part of its BEATdiabetes program that is currently undergoing pilot studies.
Additionally, Nemaura has launched a beta trial of Miboko, a metabolic health and well-being program using a non-invasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one's overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being.
The Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023.
Recent NMRD News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/01/2024 11:59:03 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/01/2024 11:00:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:28 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 04/19/2024 08:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:05:11 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/17/2024 10:17:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/17/2024 10:15:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 10:30:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 10:29:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 12:00:07 PM
- Important Update on Listing Status and Strategic Direction • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 01:00:08 PM
- Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision • GlobeNewswire Inc. • 12/13/2023 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/07/2023 03:46:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 01:38:51 PM
- Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth • GlobeNewswire Inc. • 11/21/2023 01:30:00 PM
- Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs • GlobeNewswire Inc. • 11/14/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:26 PM
- Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 09:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:05:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:10:28 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM